Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-nucleoside reverse transcriptase inhibitors: a review.

L Waters1, L John, M Nelson

  • 1Department of HIV/GU Medicine, Chelsea & Westminster Hospital, London, UK.

International Journal of Clinical Practice
|January 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stroke recovery patterns and predictors in India: A post-hoc analysis from the ATTEND trial.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Virulome and phylogenomic profiling of a novel Burkholderia pseudomallei strain from an Indian clinical isolate.

Molecular genetics and genomics : MGG·2024
Same author

A novel loop-mediated isothermal amplification (LAMP) assay to diagnose feline panleukopenia.

Journal of the South African Veterinary Association·2024
Same author

Cross-sectional survey of sexual health professionals' experiences and perceptions of the 2022 mpox outbreak in the UK.

BMJ open·2024
Same author

Diabetes mellitus is not a predictor of poor TB treatment outcomes.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions.

The Journal of hospital infection·2022
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Non-nucleoside reverse transcriptase inhibitors like nevirapine and efavirenz are vital for HIV treatment due to their efficacy and tolerability. This review examines their use, resistance, toxicity, and nevirapine

Area of Science:

  • Antiviral Therapy
  • HIV/AIDS Research
  • Pharmacology

Background:

  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are foundational in antiretroviral therapy for Human Immunodeficiency Virus (HIV).
  • Their favorable tolerability, reduced pill burden, and proven efficacy make NNRTIs a common selection for initial HIV treatment regimens.
  • Nevirapine and efavirenz represent key agents within this crucial drug class.

Purpose of the Study:

  • To provide a comprehensive review of nevirapine and efavirenz.
  • To analyze their efficacy, resistance profiles, and toxicity.
  • To specifically focus on the role of nevirapine in preventing mother-to-child transmission of HIV in resource-limited settings.

Main Methods:

  • Literature review of existing studies on nevirapine and efavirenz.

Related Experiment Videos

  • Comparative analysis of efficacy, resistance, and toxicity data.
  • Examination of clinical trial outcomes and observational data related to nevirapine for preventing mother-to-child transmission.

    • Main Results:

    • Nevirapine and efavirenz demonstrate significant efficacy in suppressing HIV replication.
    • Emergence of drug resistance can occur with prolonged use or suboptimal adherence.
    • Toxicity profiles vary, requiring careful patient monitoring.

    Conclusions:

    • Nevirapine and efavirenz remain important options for first-line HIV therapy.
    • Understanding resistance patterns and managing toxicities are critical for long-term treatment success.
    • Nevirapine plays a vital role in preventing mother-to-child HIV transmission, particularly in developing countries.